Anthracycline Medications (Doxorubicin)
- PMID: 31869097
- Bookshelf ID: NBK551633
Anthracycline Medications (Doxorubicin)
Excerpt
Doxorubicin is an anthracycline class medication used to manage and treat various types of malignancies and tumors. This activity will highlight the mechanism of action, adverse event profile, and other factors, including off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, and relevant interactions.
Copyright © 2026, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Meyer M, Seetharam M. First-Line Therapy for Metastatic Soft Tissue Sarcoma. Curr Treat Options Oncol. 2019 Jan 24;20(1):6. - PubMed
-
- Megías-Vericat JE, Martínez-Cuadrón D, Sanz MÁ, Poveda JL, Montesinos P. Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review. Expert Rev Clin Pharmacol. 2019 Mar;12(3):197-218. - PubMed
-
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet] National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda (MD): 2021. Sep 10, Cytotoxic Antibiotics.
-
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet] National Institute of Diabetes and Digestive and Kidney Diseases; Bethesda (MD): 2018. Jan 15, Doxorubicin.
Publication types
LinkOut - more resources
Full Text Sources